Skip to main content
. Author manuscript; available in PMC: 2023 Jan 15.
Published in final edited form as: Birth Defects Res. 2022 Jan 4;114(2):80–89. doi: 10.1002/bdr2.1973

Table 3.

Mean and median expenditure and range in 2016 dollars by claim service category for Medicaid-enrolled infants with birth defects potentially related to Zika virus infection and Medicaid-enrolled infants with no reported birth defects during the first year of life in North Carolina, 2011–2016

Claim service category Infants with birth defects potentially related to Zika virus infection (n = 551)
Infants with no reported birth defects (n = 365,318)
Mean expenditure ratio
Mean (SD) Median (IQR) Range Mean (SD) Median (IQR) Range
<60 days
 Total paid 34,836 (81,129) 11,192 (33,462) 2–1,226,719 2,889 (9,401) 1,233 (690) 0–1,198,903 12.1*
 Inpatient facility 28,031 (75,773) 6,389 (26,266) 0–1,176,938 1,977 (8,236) 586 (308) 0–1,176,231 14.2*
 Outpatient facility 377 (989) 0 (319) 0–10,084 59 (225) 0 (19) 0–17,357 6.4*
 Professional/physician 5,765 (7,439) 2,477 (7,453) 0–49,763 682 (1,552) 410 (314) 0–36,900 8.5*
 Drug/pharmacy 38 (162) 0 (16) 0–2,113 13 (105) 0 (0) 0–32,321 2.9*
<365 days
 Total paid 69,244 (134,362) 30,544 (64,056) 21–2,107,324 4,771 (13,809) 2,541 (2,044) 0–3,191,215 14.5*
 Inpatient facility 39,156 (106,890) 13,795 (32,172) 0–1,925,587 2,159 (10,193) 587 (338) 0–2,580,705 18.1*
 Outpatient facility 3,213 (4,018) 1,860 (3,806) 0–26,637 334 (807) 98 (360) 0–136,750 9.6*
 Professional/physician 12,932 (20,227) 6,774 (11,519) 0–188,971 1,576 (2,529) 1,204 (830) 0–167,985 8.2*
 Drug/pharmacy 5,164 (24,171) 254 (1,603) 0–294,689 231 (2,188) 47 (146) 0–544,974 22.4*
*

p < 0.05 by chi-square test.